1,170 results on '"Zyromski, Nicholas J."'
Search Results
52. Venous Thromboembolism in Necrotizing Pancreatitis: an Underappreciated Risk
53. Antibiotic irrigation during pancreatoduodenectomy to prevent infection and pancreatic fistula: A randomized controlled clinical trial
54. High Rates of Readmission in Necrotizing Pancreatitis: Natural History or Opportunity for Improvement?
55. The Dilemma of the Dilated Main Pancreatic Duct in the Distal Pancreatic Remnant After Proximal Pancreatectomy for IPMN
56. Travel distance affects rates and reasons for inpatient visits after pancreatectomy
57. Sphincter of Oddi Dysfunction After Gastric Bypass: Surgical or Endoscopic Therapy?
58. Clinical criteria for integrated molecular pathology in intraductal papillary mucinous neoplasm: less is more
59. Post-Pancreaticoduodenectomy Outcomes and Epidural Analgesia: A 5-year Single-Institution Experience
60. Evidence Versus Practice in Early Drain Removal After Pancreatectomy
61. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
62. Outcomes of pancreatoduodenectomy in the cirrhotic patient: risk stratification and meta-analysis
63. Annular pancreas: endoscopic and pancreatographic findings from a tertiary referral ERCP center
64. Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer
65. Response to Letter to Editor Regarding “Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468)”
66. Rediscover: An Italian and international consensus meeting on locally advanced pancreatic Cancer
67. Necrotizing Pancreatitis: Best Approaches
68. DNA profile components predict malignant outcomes in select cases of intraductal papillary mucinous neoplasm with negative cytology
69. Sequential drain amylase to guide drain removal following pancreatectomy
70. Evolving treatment of necrotizing pancreatitis
71. Cancer history: A predictor of IPMN subtype and dysplastic status?
72. Response to Letter to Editor Regarding: “Colon Involvement in Necrotizing Pancreatitis: Incidence, Risk Factors, and Outcomes” (Ann Surg 2020 Jul 7. Online Ahead of Print; PMID: 32649468)
73. Management of Postoperative Bile Duct Stricture
74. Chronic Pancreatitis
75. Prospective Evaluation of Associations between Cancer-Related Pain and Perineural Invasion in Patients with Resectable Pancreatic Adenocarcinoma
76. The Impact of Hepaticojejunostomy Leaks After Pancreatoduodenectomy: a Devastating Source of Morbidity and Mortality
77. Impact of Fellow Versus Resident Assistance on Outcomes Following Pancreatoduodenectomy
78. Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?
79. Management of Undifferentiated Solitary Mucinous Cystic Lesion of the Pancreas: A Clinical Dilemma
80. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
81. The American Association for the Surgery of Trauma emergency surgery guidelines for acute pancreatitis: Are we missing significant opportunities for reflection?
82. Surgical Transgastric Necrosectomy for Necrotizing Pancreatitis: A Single-stage Procedure for Walled-off Pancreatic Necrosis
83. Open Pancreatic Debridement in Necrotizing Pancreatitis
84. Su1436 NATIONWIDE TRENDS IN POSTOPERATIVE OUTCOMES AFTER DISTAL PANCREATECTOMY FOR CHRONIC PANCREATITIS
85. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
86. Portal Vein Pruning During Intraportal Islet Autotransplant: Harbinger of More Sinister Pathology?
87. Systematic review of hypertriglyceridemia-induced acute pancreatitis: A more virulent etiology?
88. Adipocytes enhance murine pancreatic cancer growth via a hepatocyte growth factor (HGF)-mediated mechanism
89. A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma
90. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma
91. Intraductal papillary mucinous neoplasm of the pancreas, one manifestation of a more systemic disease?
92. Pancreaticojejunostomy Stricture After Pancreatoduodenectomy: Outcomes After Operative Revision
93. The natural history of pancreatic lipoma: Does it need observation
94. Transgastric Pancreatic Debridement: a Step-by-step Guide to a Single-staged Procedure for Walled-off Pancreatic Necrosis
95. Invasive, mixed-type intraductal papillary mucinous neoplasm: Superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm
96. Reducing Readmissions after Pancreatectomy: Limiting Complications and Coordinating the Care Continuum
97. Does Pancreatic Stump Closure Method Influence Distal Pancreatectomy Outcomes?
98. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
99. Extended distal pancreatectomy for pancreatic adenocarcinoma with splenic vein thrombosis and/or adjacent organ invasion
100. The Value of Drains as a Fistula Mitigation Strategy for Pancreatoduodenectomy: Something for Everyone? Results of a Randomized Prospective Multi-institutional Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.